These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 25566590)

  • 1. [Evaluation of voriconazole oral dosage in Japan].
    Hamada Y; Kawasumi N; Hirai J; Yamagishi Y; Mikamo H
    Jpn J Antibiot; 2014 Oct; 67(5):279-84. PubMed ID: 25566590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Voriconazole concentration is inversely correlated with corticosteroid usage in immunocompromised patients.
    Imataki O; Yamaguchi K; Uemura M; Fukuoka N
    Transpl Infect Dis; 2018 Aug; 20(4):e12886. PubMed ID: 29570914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance of monitoring plasma concentration of voriconazole in a patient with liver failure: A case report.
    Liu X; Su H; Tong J; Chen J; Yang H; Xiao L; Hu J; Zhang L
    Medicine (Baltimore); 2017 Oct; 96(42):e8039. PubMed ID: 29049191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical implication of therapeutic drug monitoring on voriconazole from the aspect of the analysis for CYP2C19 gene].
    Kimura M; Yamagishi Y; Kawasumi N; Hagihara M; Hasegawa T; Mikamo H
    Jpn J Antibiot; 2010 Jun; 63(3):255-64. PubMed ID: 20976881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prophylactic administration of voriconazole with two different doses for invasive fungal infection in children and adolescents with acute myeloid leukemia.
    Sano H; Kobayashi R; Hori D; Kishimoto K; Suzuki D; Yasuda K; Kobayashi K
    J Microbiol Immunol Infect; 2018 Apr; 51(2):260-266. PubMed ID: 27329132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Prospective Study on the Usefulness of Initial Voriconazole Dose Adjustment Based on CYP2C19 Gene Polymorphism Analysis.
    Tanaka R; Fujioka T; Suzuki Y; Iwao M; Itoh H
    Chemotherapy; 2020; 65(3-4):59-64. PubMed ID: 32877905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tacrolimus blood concentration increase depends on administration route when combined with voriconazole in pediatric stem cell transplant recipients.
    Utano T; Kato M; Osumi T; Shioda Y; Kiyotani C; Terashima K; Tomizawa D; Matsumoto K; Yamatani A
    Pediatr Transplant; 2020 Feb; 24(1):e13619. PubMed ID: 31820535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful treatment of Aspergillus empyema using combined intrathoracic and intravenous administration of voriconazole: A case report.
    Takatsuka H; Yamazaki S; Watanabe A; Yokoyama I; Suzuki T; Kamei K; Ishii I
    J Infect Chemother; 2020 Aug; 26(8):847-850. PubMed ID: 32414688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of azole antifungal drugs on blood tacrolimus levels after switching from intravenous tacrolimus to once-daily modified release tacrolimus in patients receiving allogeneic hematopoietic stem cell transplantation.
    Mimura A; Yamaori S; Ikemura N; Katsuyama Y; Matsuzawa N; Ohmori S
    J Clin Pharm Ther; 2019 Aug; 44(4):565-571. PubMed ID: 30950099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Population Pharmacokinetics of Voriconazole in Patients With Invasive Aspergillosis: Serum Albumin Level as a Novel Marker for Clearance and Dosage Optimization.
    Chantharit P; Tantasawat M; Kasai H; Tanigawara Y
    Ther Drug Monit; 2020 Dec; 42(6):872-879. PubMed ID: 32947557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of oral voriconazole during chemotherapy for acute myeloid leukemia and myelodysplastic syndrome: a Japanese nationwide retrospective cohort study.
    Tsutsumi I; Kunisawa S; Yoshida C; Seki M; Komeno T; Fushimi K; Morita S; Imanaka Y
    Int J Clin Oncol; 2019 Nov; 24(11):1449-1458. PubMed ID: 31300904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Positive correlation between voriconazole trough concentrations and C-reactive protein levels in patients with chronic pulmonary aspergillosis: A retrospective cohort study.
    Miyakawa-Tanaka K; Suzuki J; Hirasawa Y; Nakamura S; Takeda K; Narumoto O; Matsui H
    J Infect Chemother; 2023 Jul; 29(7):683-687. PubMed ID: 36965708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic and Adsorptive Analyses of Administration of Oral Voriconazole Suspension via Enteral Feeding Tube in Intensive Care Unit Patients.
    Tanaka R; Eto D; Goto K; Ohchi Y; Yasuda N; Suzuki Y; Tatsuta R; Kitano T; Itoh H
    Biol Pharm Bull; 2021; 44(5):737-741. PubMed ID: 33952830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous micafungin versus voriconazole for chronic pulmonary aspergillosis: a multicenter trial in Japan.
    Kohno S; Izumikawa K; Ogawa K; Kurashima A; Okimoto N; Amitani R; Kakeya H; Niki Y; Miyazaki Y;
    J Infect; 2010 Nov; 61(5):410-8. PubMed ID: 20797407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors affecting voriconazole concentration to dose ratio changes according to route of administration.
    Chen C; Xu T; Zhou K; Zhu S
    Eur J Hosp Pharm; 2023 Dec; 31(1):31-35. PubMed ID: 35273002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative study of prophylaxis with high and low doses of voriconazole in children with malignancy.
    L Kandaurava S; S Baslyk K; A Migas A; V Hill A; I Bydanov O; A Mishkova V; V Aleinikova O
    Curr Med Mycol; 2020 Dec; 6(4):27-34. PubMed ID: 34195457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A retrospective, multicenter study of voriconazole trough concentrations and safety in patients with Child-Pugh class C cirrhosis.
    Wang T; Yan M; Tang D; Xue L; Zhang T; Dong Y; Zhu L; Wang X; Dong Y
    J Clin Pharm Ther; 2018 Dec; 43(6):849-854. PubMed ID: 29893015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic drug monitoring of voriconazole in Japanese patients: analysis based on clinical practice data.
    Matsumoto K; Abematsu K; Shigemi A; Kanazawa N; Watanabe E; Yokoyama Y; Ikawa K; Morikawa N; Takeda Y
    J Chemother; 2016 Jun; 28(3):198-202. PubMed ID: 26187373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Voriconazole trough concentration and hepatotoxicity in patients with low serum albumin
.
    Hirata A; Noto K; Ota R; Yokoyama S; Hosomi K; Takada M; Matsuoka H
    Int J Clin Pharmacol Ther; 2019 Mar; 57(3):135-143. PubMed ID: 30686290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral administration and younger age decrease plasma concentrations of voriconazole in pediatric patients.
    Kato K; Nagao M; Yamamoto M; Matsumura Y; Takakura S; Fukuda K; Ichiyama S
    J Infect Chemother; 2016 Jan; 22(1):27-31. PubMed ID: 26538245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.